Immunohistochemical evaluation of cell proliferation and apoptosis markers in ovarian surface epithelial cells of cladribine-treated rats

Cladribine has been used in the treatment of hairy cell leukemia for about 30 years. In addition, the number of indications for the application of 2-CdA is constantly increasing. The treatment with cladribine, of younger persons and even children, appears to be a major factor stimulating the more exact recognition of its activities. However, till now, little has been known about the impact of cladribine on the reproductive system. The aim of the study was to evaluate the immunohistochemical expression of cell proliferation and apoptosis markers in ovarian surface epithelial (OSE) cells. In our study, ten rats were placed into two equal groups. The study group received daily subcutaneous injections of cladribine in a dose of 0.10 mg/kg of weight/day for one cycle lasting 7 days. The control group received only saline injections. The rats were sacrificed 24 h after the last injection, and their ovaries were extracted. The sections were immunohistochemically stained with cell proliferation marker Ki-67 and the apoptosis marker caspase 3. The expressions of the markers were evaluated using a light microscope. An analysis was made using an image analysis system and the CellAD software. The results were then statistically explored by way of the Mann–Whitney U test. The proliferative index (Ki-67) of ovarian surface epithelial cells was significantly lower in the study group than in the control group (p?<?0.05). These results suggest that cladribine treatment has a potential to inhibit the OSE cell proliferation in rats. The apoptosis marker demonstrated a significant increase after the cladribine treatment. These suggest that cladribine induces apoptosis in OSE cells.     

Regulation of leptin secretion from white adipocytes by insulin, glycolytic substrates, and amino acids

The aim of the present study was to determine the respective roles of energy substrates and insulin on leptin secretion from white adipocytes. Cells secreted leptin in the absence of glucose or other substrates, and addition of glucose (5 mM) increased this secretion. Insulin doubled leptin secretion in the presence of glucose (5 mM), but not in its absence. High concentrations of glucose (up to 25 mM) did not significantly enhance leptin secretion over that elicited by 5 mM glucose. Similar results were obtained when glucose was replaced by pyruvate or fructose (both 5 mM). L-Glycine or L-alanine mimicked the effect of glucose on basal leptin secretion but completely prevented stimulation by insulin. On the other hand, insulin stimulated leptin secretion when glucose was replaced by L-aspartate, L-valine, L-methionine, or L-phenylalanine, but not by L-leucine (all 5 mM). Interestingly, these five amino acids potently increased basal and insulin-stimulated leptin secretion in the presence of glucose. Unexpectedly, L-glutamate acutely stimulated leptin secretion in the absence of glucose or insulin. Finally, nonmetabolizable analogs of glucose or amino acids were without effects on leptin secretion. These results suggest that 1) energy substrates are necessary to maintain basal leptin secretion constant, 2) high availability of glycolysis substrates is not sufficient to enhance leptin secretion but is necessary for its stimulation by insulin, 3) amino acid precursors of tricarboxylic acid cycle intermediates potently stimulate basal leptin secretion per se, with insulin having an additive effect, and 4) substrates need to be metabolized to increase leptin secretion.     

Sugar Uptake and Utilisation during Adventitious Bud Differentiation on in Vitro Leaf Explants of ‘Wegierka Zwykła’ Plum (Prunus Domestica)

Leaf explants of plum Wegierka Zwyka were cultured on modified MS medium supplemented with 7.5 µM TDZ (thidiazuron) and 0.9 µM 2,4-D (2,4-dichlorophenoxyacetic acid), with the addition of either sucrose or glucose at a concentration of 2%, 3%, 4%, 5% or 6% (w/v). Regeneration was carried out in two steps: the first in darkness, the second in photoperiod conditions after subculture onto fresh medium. The study assessed the influence of the kind of sugar used and its concentration in the medium on organogenesis efficiency, and on sugar uptake from the medium. The results suggest that sucrose is a better carbon source than glucose for organogenesis of Wegierka Zwyka, even though at lower concentrations the efficiency of the sugars was comparable. With increasing concentration of sugars, the efficiency of organogenesis decreased, a relation more evident for media with glucose. In the first (dark) step of regeneration, the explants utilised less carbohydrates from the media than in the second step, when the main increase of explant weight took place. In the second phase, at 2–5% concentrations glucose uptake was higher than sucrose uptake.     

Über Vitalfärbung des Golgi-Apparates und der ergastoplasmatischen Strukturen in einigen Gastropoden-Zellen

Zusammenfassung In Gastropoden-Zellen färbt sich das Vakuom vital mit Neutralrot, der Golgi-Apparat dagegen nicht. Mit Ausnahme der Spermatocyten und Spermatiden ist der Golgi-Apparat in allen anderen Zellen im lebenden, ungefärbten Zustande, unsichtbar. Der Golgi-Apparat läßt sich aber durch folgendes Verfahren, vital gefärbt, sichtbar machen: Die Zellen werden mit einer isotonischen Ammoniumchloridlösung behandelt (eine Stunde), dann in einer isotonischen Kochsalzlösung gewaschen und schließlich in einer isotonischen Natriumbikarbonatlösung, welche die Farbstoffe Dahlia und Chrysoidin enthält, gefärbt (15 Minuten). Die schönsten Resultate erhielt der Verfasser an Speicheldrüsenzellen vonHelix. Unter der Einwirkung von Ammoniumchlorid werden die Lipoid-Eiweiß-Verbindungen in geringer Menge aufgespalten, um die freigewordenen Lipoide des Golgi-Apparates mit basischen Farbstoffen färben zu können. Die ergastoplasmatischen Strukturen werden sichtbar, wenn die Speicheldrüsenzellen mit einer isotonischen Natriumbikarbonatlösung behandelt (15 bis 30 Minuten) und dann mit Dahlia gefärbt werden.     

Stimulatory effect of vasoactive intestinal peptide (VIP) on the secretory activity of dispersed rat adrenocortical cells. Evidence for the interaction of VIP with ACTH receptors

VIP dose-dependently increased basal, but not submaximally ACTH (10⁻¹⁰ M)-stimulated, aldosterone (ALDO) and corticosterone (B) secretion of dispersed rat capsular and inner adrenocortical cells, respectively. The maximal stimulatory effect (60–70% rise) was obtained with a VIP concentration of 10⁻⁸ M. [4-Cl-D-Phe⁶,Leu¹⁷]-VIP, a VIP-receptor antagonist (VIP-A), and corticotropin inhibiting peptide (CIP), an ACTH receptor antagonist (both 10⁻⁶ M), completely annulled VIP (10⁻⁸M)-evoked rises in basal ALDO and corticosterone secretions. The ACTH (10⁻¹⁰ M)-enhanced (about 5-fold) production of both hormones was completely reversed by CIP (10⁻⁶ M) and only partially reduced (about −30%) by VIP-A (10⁻⁶ M). The hypothesis is advanced that the weak secretagogue effect of VIP on dispersed rat capsular and inner adrenocortical cells may be due to its positive interaction with ACTH receptors.     

Comparison of the Lipolytic Effects of Norepinephrine and BRL 37344 in Rat Brown and White Adipocytes

The lipolytic effects of norepinephrine (a non-selective β-agonist) and BRL 37344 (a selective β₃-agonist) were compared in isolated rat brown and white adipocytes. Norepinephrine and BRL 37344 maximally stimulated lipolysis in brown and white adipocytes, approximately 10 times above basal values. However, adipocyte sensitivity for BRL 37344 was greater than that for norepinephrine, particularly in brown adipocytes [the EC₅₀ values (nM) for BRL 37344 and norepinephrine were 5 ± 1 and 103 ± 31 in brown adipocytes (P <0.01) versus 56 ± 9 and 124 ± 17 in white adipocytes (P <0.05), respectively]. On the other hand, the lipolytic effects of norepinephrine were totally blocked by 20–40 times superior concentrations of propranolol or bupranolol in brown as well as in white adipocytes. In contrast, the lipolytic effects of BRL 37344 were fully inhibited by concentrations of propranolol or bupranolol that were 200–1000 superior to the β₃ agonist concentration. The results demonstrate that: (1) the (β₃-agonist BRL 37344 is as effective as norepinephrine for maximally stimulating lipolysis in rat brown and white adipocytes, (2) both adipocyte types are more sensitive to the lipolytic effects of BRL 37344 than to those of norepinephrine, (3) although bupranolol is a better antagonist than propranolol on BRL 37344-stimulated lipolysis, it cannot be considered as a specific β₃-antagonist, (4) brown adipocytes are 10 times more sensitive than white adipocytes to the lipolytic effects of BRL 37344, suggesting an important role of β₃-receptors in brown adipose tissue.